Position in TRVI
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$14,518,271
+$810,738 QoQ
Shares Held
1,216,955
+11.2% QoQ
Ownership
0.857%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 91.71127938173557.ToString("F0")%
Shared 0.ToString("F0")%
None 8.288720618264438.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,554,846,017 across 346 Biotechnology names. TRVI ranks #87 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in TRVI
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,518,271 | 1,216,955 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $13,707,533 | 1,094,851 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $16,807,075 | 1,836,839 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $6,003,308 | 1,097,497 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $828,800 | 131,765 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $187,323 | 45,467 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $159,474 | 47,747 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $131,966 | 44,284 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $75,816 | 21,976 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $56,269 | 41,992 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $62,550 | 28,693 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $89,840 | 37,590 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $176 | 92 | Shares | Defined | 2023-02-10 | |
| 2021-03-31 | $43 | 16 | Shares | Defined | 2021-05-14 | |
| 2020-09-30 | $721 | 179 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $263 | 40 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||